Thomas K Equels is CEO & President of AIM ImmunoTech Inc.. Currently has a direct ownership of 38,885 shares of AIM, which is worth approximately $353,853. The most recent transaction as insider was on Dec 13, 2021, when has been sold 21,552 shares (Common Stock) at a price of $1.16 per share, resulting in proceeds of $25,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 38.9K
98.99% 3M change
95.0% 12M change
Total Value Held $353,853

Thomas K Equels Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 13 2021
BUY
Grant, award, or other acquisition
$25,000 $1.16 p/Share
21,552 Added 6.69%
300,789 Common Stock
Dec 10 2021
BUY
Grant, award, or other acquisition
$15,000 $1.27 p/Share
11,811 Added 4.06%
279,237 Common Stock
Nov 24 2021
BUY
Grant, award, or other acquisition
$14,999 $1.29 p/Share
11,627 Added 4.17%
267,426 Common Stock
Nov 23 2021
BUY
Grant, award, or other acquisition
$15,000 $1.34 p/Share
11,194 Added 4.19%
255,799 Common Stock
Nov 19 2021
BUY
Grant, award, or other acquisition
$15,000 $1.47 p/Share
10,204 Added 4.0%
244,605 Common Stock
Nov 17 2021
BUY
Grant, award, or other acquisition
$14,999 $1.64 p/Share
9,146 Added 3.76%
234,401 Common Stock
Jul 16 2021
BUY
Open market or private purchase
$30,000 $1.92 p/Share
15,625 Added 6.49%
225,255 Common Stock
Feb 24 2021
BUY
Open market or private purchase
$25,000 $2.26 p/Share
11,062 Added 5.01%
209,630 Common Stock
Dec 17 2020
BUY
Open market or private purchase
$25,000 $1.72 p/Share
14,535 Added 6.82%
198,568 Common Stock
TKE

Thomas K Equels

CEO & President
Ocala, FL

Track Institutional and Insider Activities on AIM

Follow AIM ImmunoTech Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AIM shares.

Notify only if

Insider Trading

Get notified when an Aim Immuno Tech Inc. insider buys or sells AIM shares.

Notify only if

News

Receive news related to AIM ImmunoTech Inc.

Track Activities on AIM